For Investors
We help investment and portfolio teams de-risk growth plans by diagnosing execution risk early, translating the value thesis into intervention pathways, and installing the commercial operating rhythm that closes the gap between target, forecast and actuals.
It’s more than portfolio support. It’s an execution-risk operating system.
Most portfolio growth plans assume execution will improve. In reality, the gap is often in: pipeline quality, forecast reliability , deal control - seller capability, operating rhythm, commercial infrastructure
Value creation leads
Portfolio ops teams
Investment teams
Chairs / operating partners
CEOs / CROs in portfolio companies
The pattern lens
Enough qualified pipeline?
Does it convert and move?
Can management trust the number?
Is growth becoming repeatable?
What we install (end-to-end)
Operator layer

$500K+ ARR pipeline in 60 days
12× deal size; 70% pipeline via partners

Scaled Pega ARR $9m → $54m (6× growth)
Doubled Virtalis ARR £4m → £8m in 2yrs




Grew Concentra £0 → £19m ARR in 4yrs
Drove ChatLingual to 50% of global revenue in 18 mos




70% Growth in Okta large Enterprise year on year
Doubled Critizr MRR, open new markets - UKI, DACH

.png)
.png)
.png)
7 % utilisation uplift unlocked €10 m+ margin at IFS
Grew €34 m services unit 4 out of 5 yrs; twice “global best of class"
.png)



Co-founded and grew Aqfer; built repeatable GTM motions.
US CRO; designs and runs full-funnel GTM for scale.

CrossVista: €400K → €1.9M (5×); 17 enterprise wins (68% win rate)
SI + retention: 30%+ pipeline via Accenture/Cognizant/Capgemini; 90% GRR (25 accounts)




Led €200m EMEA P&L at Deutsche Bank (17 markets)
Returned Tungsten sales to +18% YoY; scaled Bleckwen pipeline €7m→€35m.